Literature DB >> 2589652

In vitro study on mechanisms of bupivacaine-induced depression of myocardial contractility.

J J Eledjam1, J E de La Coussaye, J Brugada, B Bassoul, J P Gagnol, J R Fabregat, C Massé, A Sassine.   

Abstract

Although several mechanisms have been proposed to explain bupivacaine cardiotoxicity, the predominant effect remains to be determined. In this study, we used an isolated rabbit right atrial model that reproduces the effects on inotropic and chronotropic functions induced by 0.5 micrograms/mL bupivacaine; then we tried to counteract these events by electrical stimulation or by addition of CaCl2 or adenosine triphosphate (ATP) to the bathing solution. Contractile force was dramatically depressed by bupivacaine alone (-68%), even when the preparation was paced (-59%). CaCl2 partially counteracted this decrease (-37%). Inotropic function was almost completely restored (-9%) when ATP was added before administration of bupivacaine. Inhibition of energy metabolism seems to be a major explanation for bupivacaine cardiotoxicity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589652

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  14 in total

1.  Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats.

Authors:  Parisa Partownavid; Soban Umar; Jingyuan Li; Siamak Rahman; Mansoureh Eghbali
Journal:  Crit Care Med       Date:  2012-08       Impact factor: 7.598

Review 2.  Local anesthetics.

Authors:  J A Yagiela
Journal:  Anesth Prog       Date:  1991 Jul-Oct

3.  Cardiac depression induced by cocaine or cocaethylene is alleviated by lipid emulsion more effectively than by sulfobutylether-β-cyclodextrin.

Authors:  Michael R Fettiplace; Adrian Pichurko; Richard Ripper; Bocheng Lin; Katarzyna Kowal; Kinga Lis; David Schwartz; Douglas L Feinstein; Israel Rubinstein; Guy Weinberg
Journal:  Acad Emerg Med       Date:  2015-04-23       Impact factor: 3.451

4.  Bupivacaine-induced slow-inward current inhibition: a voltage clamp study on frog atrial fibres.

Authors:  J E de La Coussaye; C Massé; B P Bassoul; J J Eledjam; J P Gagnol; A Sassine
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

Review 5.  Cardiotoxicity with modern local anaesthetics: is there a safer choice?

Authors:  L E Mather; D H Chang
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 6.  Intravenous lipid emulsion in clinical toxicology.

Authors:  Leelach Rothschild; Sarah Bern; Sarah Oswald; Guy Weinberg
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-10-05       Impact factor: 2.953

7.  Hypoglycemia enhances bupivacaine-induced cardiotoxicity in the rat.

Authors:  G P Lu; S S Schwalbe; G F Marx; G Batiller; R Limjoco
Journal:  J Anesth       Date:  1992-07       Impact factor: 2.078

8.  Resuscitation with lipid emulsion: dose-dependent recovery from cardiac pharmacotoxicity requires a cardiotonic effect.

Authors:  Michael R Fettiplace; Belinda S Akpa; Richard Ripper; Brian Zider; Jason Lang; Israel Rubinstein; Guy Weinberg
Journal:  Anesthesiology       Date:  2014-04       Impact factor: 7.892

9.  Insulin Signaling in Bupivacaine-induced Cardiac Toxicity: Sensitization during Recovery and Potentiation by Lipid Emulsion.

Authors:  Michael R Fettiplace; Katarzyna Kowal; Richard Ripper; Alexandria Young; Kinga Lis; Israel Rubinstein; Marcelo Bonini; Richard Minshall; Guy Weinberg
Journal:  Anesthesiology       Date:  2016-02       Impact factor: 7.892

10.  The protective effect of lipid emulsion in preventing bupivacaine-induced mitochondrial injury and apoptosis of H9C2 cardiomyocytes.

Authors:  Zhe Chen; Zhousheng Jin; Yun Xia; Shishi Zhao; Xuzhong Xu; Thomas J Papadimos; Quanguang Wang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.